Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Trishula Therapeutics, Inc.
Seagen Inc.
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)